Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Scientific Inds Inc (OP: SCND )

1.750 +0.040 (+2.34%)
Streaming Delayed Price Updated: 9:33 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 100
Open 1.710
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 1.710
Today's Range 1.750 - 1.750
52wk Range 0.1820 - 5.170
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Scientific Industries Announces Appointment of Industry Leader Michael Blechman as New Board Member
Via ACCESSWIRE
Scientific Industries to Host Full Year 2023 Financial Results Investor Call on April 3, 2024
Via ACCESSWIRE

Performance

YTD
-27.08%
-27.08%
1 Month
+23.24%
+23.24%
3 Month
-12.50%
-12.50%
6 Month
-57.00%
-57.00%
1 Year
-61.54%
-61.54%

More News

Read More
Scientific Industries Reports Financial Results for Full Year Ended December 31, 2023 and Launches New VIVID-LITE S Pill Counter
Via ACCESSWIRE
Scientific Industries Announces Industry Veteran, John Nicols, as New Board Member and Chairman of Scientific Bioprocessing Inc.
Via ACCESSWIRE
Scientific Industries Announces Closing of $7.0 Million Private Placement
Via ACCESSWIRE
Scientific Industries Reports Financial Results for Third Quarter 2023
Via ACCESSWIRE
Scientific Industries to Report Third Quarter 2023 Financial Results on November 14, 2023
Via ACCESSWIRE
Scientific Industries Appoints Bioprocessing Industry Veteran as New Strategic Advisor
Via ACCESSWIRE
Scientific Industries Reports Financial Results for Second Quarter 2023
Via ACCESSWIRE
Scientific Industries to Report Second Quarter 2023 Financial Results on August 14, 2023
Via ACCESSWIRE
Scientific Industries' Bioprocessing Systems Operations ("SBI") Unveils Expanded DOTS Platform Revolutionizing Shake Flask Bioprocessing
Via ACCESSWIRE
Scientific Industries to Participate in the Healthcare IT Virtual Conference Part II Presented by Maxim Group LLC and Hosted by M-Vest on Thursday, June 1, 2023 at 9:00 A.M. ET
Via ACCESSWIRE
Scientific Industries Reports Financial Results for First Quarter of Fiscal Year 2023
Via ACCESSWIRE
Scientific Industries to Report First Quarter 2023 Financial Results on May 15, 2023
Via ACCESSWIRE
Scientific Industries Reports Financial Results for Six Month Transition Period Ended December 31, 2022; Discloses Non-Cash Restatement of Certain Previously Issued Financial Statements
Via ACCESSWIRE
Scientific Industries to Present at the Maxim Healthcare IT Virtual Conference and Participate in Lytham Partners Investor Select Conference
Via ACCESSWIRE
Scientific Industries Launches New VIVID(R) LITE Automated Pill Counter
Via ACCESSWIRE
Scientific Industries Reports First Quarter Fiscal Year 2023 Financial Results
Via ACCESSWIRE
Scientific Industries to Report First Quarter Fiscal Year 2023 Financial Results on November 14, 2022
Via ACCESSWIRE
Scientific Industries Reports Fiscal Year 2022 Financial Results Ended June 30, 2022
Via ACCESSWIRE
Scientific Industries to Report Fiscal Year 2022 Financial Results on September 29, 2022
Via ACCESSWIRE
Scientific Industries to Present at the Lytham Fall 2022 Investor Conference
Via ACCESSWIRE
Scientific Industries Announces Research Collaboration Incorporating DOTS(TM), The New Sensor Platform to Digitally Simplify Bioprocessing
Via ACCESSWIRE
Scientific Industries' Scientific Bioprocessing (SBI) Introduces DOTS, The New Sensor Platform to Digitally Simplify Bioprocessing
Via ACCESSWIRE
Scientific Industries Integrates Important New Features into its VIVID Pill Counting Solution to Deliver Digitally Simplified Pharmacy Automation
From Scientific Industries, Inc.
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.